India's patent laws are unique, featuring stringent criteria for patentability, particularly for secondary patents. To secure approval, these patents must demonstrate a significant therapeutic improvement. This distinctive approach has effectively deterred evergreening practices by pharmaceutical companies, aligning with India's dedication to public health and affordable blockbuster medicines.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment